KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $6.22.

  • Eli Lilly's EPS (Basic) rose 47592.59% to $6.22 in Q3 2025 from the same period last year, while for Sep 2025 it was $20.49, marking a year-over-year increase of 12055.97%. This contributed to the annual value of $11.76 for FY2024, which is 10204.06% up from last year.
  • Eli Lilly's EPS (Basic) amounted to $6.22 in Q3 2025, which was up 47592.59% from $6.3 recorded in Q2 2025.
  • Over the past 5 years, Eli Lilly's EPS (Basic) peaked at $6.3 during Q2 2025, and registered a low of -$0.06 during Q3 2023.
  • Its 5-year average for EPS (Basic) is $2.43, with a median of $1.96 in 2023.
  • In the last 5 years, Eli Lilly's EPS (Basic) crashed by 10372.67% in 2023 and then soared by 190000.0% in 2024.
  • Eli Lilly's EPS (Basic) (Quarter) stood at $1.9 in 2021, then grew by 13.16% to $2.15 in 2022, then increased by 13.02% to $2.43 in 2023, then soared by 101.5% to $4.9 in 2024, then grew by 27.03% to $6.22 in 2025.
  • Its EPS (Basic) was $6.22 in Q3 2025, compared to $6.3 in Q2 2025 and $3.07 in Q1 2025.